Systemic bioactivity of intranasal triamcinolone and mometasone in perennial allergic rhinitis

British Journal of Clinical Pharmacology

Volumn 55, Issue 3, 2003, Pages 310-313

  Lee, Daniel K C ^a   Robb, Fiona M ^a   Sims, Erika J ^a   Currie, Graeme P ^a   McFarlane, Lesley C ^a   Lipworth, Brian J ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Intranasal glucocorticoids; Mometasone furoate; Perennial allergic rhinitis; Systemic bioactivity; Triamcinolone acetonide

Indexed keywords

MOMETASONE FUROATE; TRIAMCINOLONE; TRIAMCINOLONE ACETONIDE;

ADULT; ALLERGIC RHINITIS; ARTICLE; CELL COMPARTMENTALIZATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFECT; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; OUTCOMES RESEARCH; PERENNIAL RHINITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEASONAL VARIATION; STEADY STATE;

ADMINISTRATION, INTRANASAL; ADULT; DRUG EVALUATION; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; PREGNADIENEDIOLS; RHINITIS, ALLERGIC, PERENNIAL; TRIAMCINOLONE;

EID: 0037349178     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.2003.01729.x     Document Type: Article

References (11)

1. Lipworth BJ, Seckl JR. Measures for detecting systemic bioactivity with inhaled and intranasal corticosteroids. Thorax 1997; 52: 476-482.
2. Wilson AM, Sims EJ, McFarlane LC, Lipworth BJ. Effects of intranasal corticosteroids on adrenal, bone, and blood markers of systemic activity in allergic rhinitis. J Allergy Clin Immunol 1998; 102: 598-604.
3. Affrime MB, Kosoglou T, Thonoor CM, Flannery BE, Herron JM. Mometasone furoate has minimal effects on the hypothalamic-pituitary-adrenal axis when delivered at high doses. Chest 2000; 118: 1538-1546.
4. Lipworth BJ, Jackson CM. Safety of inhaled and intranasal corticosteroids: lessons for the new millennium. Drug Safety 2000; 23: 11-33.
5. Thorsson L, Dahlstrom K, Edsbacker S, Kallen A, Paulson J, Wiren JE. Pharmacokinetics and systemic effects of inhaled fluticasone propionate in healthy subjects. Br J Clin Pharmacol 1997; 43: 155-161.
6. Derendorf H, Hochhaus G, Rohatagi S, et al. Pharmacokinetics of triamcinolone acetonide after intravenous, oral, and inhaled administration. J Clin Pharmacol 1995; 35: 302-305.
7. Argenti D, Shah B, Heald D. A pharmacokinetic study to evaluate the absolute bioavailability of triamcinolone acetonide following inhalation administration. J Clin Pharmacol 1999; 39: 695-702.
8. Wilson AM, Lipworth BJ. 24 hour and fractionated profiles of adrenocortical activity in asthmatic patients receiving inhaled and intranasal corticosteroids. Thorax 1999; 54: 20-26.
9. McIntyre HD, Mitchell CA, Bowler SD, Armstrong JG, Wooler JA, Cowley DM. Measuring the systemic effects of inhaled beclomethasone: timed morning urine collections compared with 24 hour specimens. Thorax 1995; 50: 1280-1284.
10. Bronsky EA, Aaronson DW, Berkowitz RB, et al. Dose ranging study of mometasone furoate (Nasonex) in seasonal allergic rhinitis. Ann Allergy Asthma Immunol 1997; 79: 51-56.
11. Munk ZM, Laforce C, Furst JA, Simpson B, Feiss G, Smith JA. Efficacy and safety, of triamcinolone acetonide aqueous nasal spray in patients with seasonal allergic rhinitis. Ann Allergy Asthma Immunol 1996; 77: 277-281.